SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Teva to Halt Phase 2 Emrusolmin Trial Over Lack of Efficacy

Teva Pharmaceuticals will halt its phase 2 TOPAS-M trial of the neurodegenerative drug emrusolmin over lack of efficacy.

TEVA

Related stories